News

Innovative Biotech Firm 28 Capital Begins New Journey

Innovative Biotech Firm 28 Capital Begins New Journey

New Horizons for 28 Capital in Biotech Innovations

In an exciting development for the biotech field, 28 Capital is setting a new course. This emerging life sciences venture capital firm, born from the successful Tiger Gene initiative, is dedicated to advancing scientific innovations into transformative therapies for patients. Co-founders John Boyce and Audrey Warner are leading the charge to bridge the gap between groundbreaking research and practical medical solutions.

The Vision Behind 28 Capital

28 Capital is not just another venture capital firm; it represents a vision of the future of medicine authored by those deeply entrenched in scientific research. By focusing on how to translate cutting-edge discoveries from academic labs into real-world applications, this firm is primed to make substantial contributions to healthcare. The company's foundational ethos is built on collaboration with leading scientists and academic institutions to nurture groundbreaking companies that fill significant gaps in medical needs.

The Predecessor: Tiger Gene

With roots tracing back to the Tiger Gene initiative, the firm is capitalizing on a proven track record of success. That original platform facilitated the emergence of innovative biotech companies that are now at the forefront of advancements in therapeutics, diagnostics, and synthetic biology. This history underscores the firm’s capability to identify key scientific breakthroughs and develop them into scalable business models focused on patient outcomes.

Strong Leadership and Expertise

Central to 28 Capital's mission are John Boyce and Audrey Warner. Boyce, who is recognized across the nation as a biotech innovator, boasts more than $1.8 billion in exit value across numerous successes in his career. With an impressive ability to generate funding—over $800 million from various sources—he has a reputation for delivering exceptional returns. His experience as a Harvard Fellow exemplifies his dual commitment to education and practical application within the biotech landscape.

Audrey Warner, similarly accomplished, complements Boyce’s leadership. As a Harvard alumna, her varsity athletic background meshes remarkably with her venture capital expertise, allowing her to approach company formation with an innovative mindset. Together, they foster a culture of conviction, commitment, and unparalleled execution that permeates the entire organization.

Building Future-Proof Biotech Solutions

The mission of 28 Capital revolves around the concept of patient-centered care, ensuring that every scientific advancement is poised to comply with pressing medical necessities. Their proactive stance engages with top-tier institutions and the best academic minds, all aimed at converting promising foundational science into successful biotech enterprises that can flourish in the ever-evolving clinical landscape.

Furthermore, their hands-on approach to company building distinguishes them from more traditional investment firms. Rather than merely providing financial backing, they immerse themselves in every stage of development—right from the conception of an idea through to its actualization and scaling.

Investment Philosophy

28 Capital’s investment strategy involves co-investment with other leading venture firms, strategic partners, and institutional investors, signaling a collaborative effort to drive forward scientific advancements. It embodies a belief that hedge capabilities resulting from shared capital and joint expertise can accelerate the journey from lab work to tangible therapeutic results.

About 28 Capital

28 Capital, based in Boston, is a venture capital firm solely dedicated to life sciences. Formerly known as Tiger Gene, the firm embodies a commitment to pioneering disruptive innovations that address substantial medical challenges. Collaborating closely with brilliant scientific minds, 28 Capital aims to not only fund but actively build the next generation of clinically impactful companies. Co-led by the dynamic duo of John Boyce and Audrey Warner, it stands ready to shape the future of healthcare.

Frequently Asked Questions

What is 28 Capital's main focus?

28 Capital focuses on translating scientific discoveries into innovative therapies that meet significant medical needs.

Who are the founders of 28 Capital?

The firm was co-founded by biotech entrepreneur John Boyce and venture capitalist Audrey Warner.

What is the significance of the name change from Tiger Gene?

The name change reflects a new direction in the firm's mission to further advance biotechnological improvements 'from lab to the patient.'

How does 28 Capital work with academic institutions?

28 Capital partners with leading scientists and institutions to facilitate the development of breakthrough biotech companies.

What is the investment strategy of 28 Capital?

The firm employs a hands-on investment model, actively participating in the entire process from inception to scale.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 154

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 101

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 227

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 16

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 127

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 124

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 130

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 112

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyramid Global Hospitality Welcomes Anthony Torres Amid Award Success

Updated Category News Views 281

Pyramid Global Hospitality Welcomes a New Leader The renowned hospitality management company, Pyramid Global Hospitality, has recently appointed Anthony Torres as its vice president of food and beverage. In this pivotal role, he will oversee the culinary vision that has underpinned the company’s award-winning reputation in the hospitality industry. Celebrating Culinary...

Continue Reading
Shamari Reid's Audiobook Earns Audie Award Nomination

Updated Category News Views 117

Shamari Reid's Audiobook Earns Audie Award Nomination Heinemann, a respected name in educational publishing, has announced that Shamari Reid's audiobook, Humans Who Teach: A Guide for Centering Love, Justice, and Liberation in Schools, has been nominated for the prestigious Audie Award in the business and personal development category. This recognition highlights the...

Continue Reading
Azazie's Summer RSVP Collection: Versatility Unleashed

Updated Category News Views 19

The Shift from Singular to Seasonal Dressing You ever get that feeling when you’re dressing for a season full of events, rather than pinning everything on just one big day? That’s what Azazie’s latest move is about, tearing up those old pages of the calendar marked just for weddings and making room for the whole shebang—every lunch, night out, and festive fling...

Continue Reading
Growing Demand for Automated Boarding Gates: Market Trends

Updated Category News Views 197

Overview of the Automatic Boarding Gates Market The automatic boarding gates market is on the rise, with expectations to reach $132.8 million by the end of the forecast period in 2032. Key factors driving this growth include an increase in air passenger traffic, ongoing technological advancements, and heightened security needs in the industry. A recent report shows that...

Continue Reading
Stride, Inc.'s Compliance Issues Under Investigation by SEC

Updated Category News Views 330

Stride, Inc. Faces Serious Investor Scrutiny Shares of Stride, Inc. (NYSE: LRN), a notable player in the educational technology sector, have seen a sharp decline in value due to recent allegations made against the company. The complaints, originating from a New Mexico school district, allege serious infractions, including fraudulent practices and conflicts of interest,...

Continue Reading